22q11.2 deletion syndrome is a genetic condition that affects many body systems from birth. People with 22q11.2 deletion syndrome often have heart differences, feeding or growth issues, and immune problems, and some have learning or speech delays. Features are lifelong, but needs change with age, and not everyone will have the same experience. Treatment focuses on managing features with heart surgery if needed, immune and calcium support, speech and learning services, and regular checkups. The outlook for 22q11.2 deletion syndrome varies, but many people live into adulthood with coordinated care.
Overview
22q11.2 deletion syndromeSymptoms
22q11.2 deletion syndrome features vary widely. Common signs include heart defects, cleft or high palate with nasal speech, feeding trouble, frequent infections, low calcium causing cramps or seizures, and developmental or learning delays. Some later develop anxiety or psychosis.
Outlook and prognosis
Most children with 22q11.2 deletion syndrome grow, learn, and form relationships, though they may need ongoing support for heart, immune, feeding, speech, or learning differences. Early, coordinated care improves health, school progress, and independence. Many adults work, parent, and lead fulfilling lives.
Causes and risk factors
22q11.2 deletion syndrome results from a missing segment on chromosome 22, usually occurring spontaneously before birth. A parent carrying the deletion raises recurrence risk (autosomal dominant inheritance). No known environmental or lifestyle causes; most pregnancies have no identifiable risk factors.
Genetic influences
Genetics are central in 22q11.2 deletion syndrome: the condition results from a small missing segment on chromosome 22. Most cases occur as new (de novo) changes; some are inherited in an autosomal dominant pattern. Genetic testing confirms the deletion and guides family counseling.
Diagnosis
Doctors suspect it based on features like heart defects, palate issues, or immune problems. Genetic tests (chromosomal microarray or FISH) confirm the deletion; prenatal diagnosis is possible via CVS or amniocentesis. This is the genetic diagnosis of 22q11.2 deletion syndrome.
Treatment and drugs
Treatment for 22q11.2 deletion syndrome is tailored to each person’s needs and often involves a coordinated team. Care may include heart surgery, calcium and thyroid support, immune management, speech and feeding therapy, learning supports, and mental health care. Regular check-ins help adjust treatments over time.
Symptoms
People with 22q11.2 deletion syndrome can have a mix of health and developmental differences that show up in infancy, childhood, or later. Early features of 22q11.2 deletion syndrome may include heart differences, feeding trouble, low calcium, or frequent infections. Features vary from person to person and can change over time. Many do well with early supports, targeted treatments, and regular follow-up.
Structural heart differences can cause fast breathing, bluish color, or tiring with feeds. In 22q11.2 deletion syndrome, some children need medicines or surgery early in life. Routine heart care helps many stay active.
A cleft palate or a soft palate that doesn’t close fully can make feeding hard and speech sound nasal. In 22q11.2 deletion syndrome, speech therapy and sometimes surgery can improve clarity. Bottle or nipple changes may also help.
Babies may have trouble sucking, reflux, or slow weight gain. Working with feeding specialists and dietitians can support growth. Tube feeding is sometimes used temporarily.
Low calcium can cause jitteriness, muscle cramps, or seizures, especially in newborns. In 22q11.2 deletion syndrome, doctors check calcium levels and give supplements when needed. Treating low calcium often eases these symptoms quickly.
How people usually first notice 22q11.2 deletion syndrome?
Many families first notice 22q11.2 deletion syndrome when a routine prenatal ultrasound shows heart differences or a cleft palate, or after birth when a baby has feeding difficulties, weak cry, or trouble gaining weight. Doctors may pick it up early because of a congenital heart defect, low calcium levels causing jitteriness or seizures, or a cleft or high-arched palate that leads to nasal-sounding speech. As children grow, the first signs of 22q11.2 deletion syndrome can also include frequent infections due to immune differences and developmental or learning delays, prompting genetic testing to confirm the diagnosis.
Types of 22q11.2 deletion syndrome
22q11.2 deletion syndrome has a few well-recognized clinical variants that reflect how much DNA is missing and where. These variants can influence heart differences, immune function, speech and palate, learning, and mental health to varying degrees. Not everyone will experience every feature, and severity can range from mild to more complex. People may notice different sets of symptoms depending on their situation.
Typical 3-Mb deletion
This is the most common variant, spanning a larger segment in the 22q11.2 region. It’s often linked with congenital heart differences, palate or speech issues, immune differences, and learning challenges. Mental health concerns in adolescence or adulthood can also occur.
Nested 1.5-Mb deletion
This smaller, “nested” deletion lies within the same region and can have a similar range of features but sometimes with milder expression. Heart and palate differences may still appear, along with feeding, growth, or learning issues. Mental health conditions can still develop over time.
Atypical proximal deletions
These involve smaller, nonstandard segments closer to the centromere within 22q11.2. Features can be variable, from very subtle to similar to the broader deletion, depending on genes involved. Early symptoms of 22q11.2 deletion syndrome may be less obvious in infancy.
Atypical distal deletions
These deletions occur toward the far end (distal) of the 22q11.2 region. They can present with learning and developmental differences and occasionally heart or skeletal findings. Because patterns vary, these types of 22q11.2 deletion syndrome can be harder to recognize early.
Mosaic deletions
Only a portion of cells carries the 22q11.2 deletion, while others do not. Symptoms can be milder or patchy because not all tissues are affected the same way. Detection sometimes requires more sensitive genetic testing.
What genetics can tell you about symptoms
Some people with a 22q11.2 deletion have heart defects, cleft palate, low calcium causing muscle cramps or seizures, immune problems with frequent infections, and learning or speech differences because missing genes in that region disrupt early organ and brain development. Specific gene losses, like TBX1 for heart and palate formation and COMT affecting attention and anxiety, help explain why symptoms cluster and vary in severity.
Causes and risk factors
22q11.2 deletion syndrome happens because a small piece of chromosome 22 is missing. Doctors distinguish between risk factors you can change and those you can’t. Most cases occur as a new change at conception, but a parent with the deletion has a 50% chance of passing it on. Pregnancy exposures do not cause the deletion, but prenatal care, nutrition, and avoidance of alcohol and tobacco can support overall fetal health. Family history is the main risk factor, and other factors mostly shape the severity and the early symptoms of 22q11.2 deletion syndrome.
Environmental and biological risk factors
When families hear about 22q11.2 deletion syndrome, a common question is what increases the chance it happens. This overview covers environmental and biological risk factors for 22q11.2 deletion syndrome. Some risks are carried inside the body, others come from the world around us. For this condition, most cases arise without a known trigger, and few outside influences have been tied to the deletion itself.
The deletion most often results from a spontaneous change as the egg or sperm forms. It is not caused by actions during pregnancy or by typical exposures. 22q11.2 deletion syndrome can occur in any pregnancy.
Unlike some chromosomal conditions, no consistent link with older maternal or paternal age has been shown. The baseline chance appears similar across age groups. Data to suggest strong age effects are lacking.
Exposure to things like radiation, heavy metals, or common pollutants has not been proven to increase the chance of this specific deletion. Research to date has not identified a clear environmental trigger for 22q11.2 deletion syndrome. Standard exposure limits and safety measures still matter for overall pregnancy health.
Infections during pregnancy can affect fetal development, but they have not been shown to cause this chromosome deletion. This change typically happens before most pregnancy exposures occur. Preventing and treating infections remains important for general pregnancy outcomes.
Genetic risk factors
Most cases start with a small missing piece of DNA on chromosome 22. 22q11.2 deletion syndrome usually happens because one copy of this region is absent, which changes how certain genes work. Some risk factors are inherited through our genes. Understanding the genetic causes of 22q11.2 deletion syndrome can guide family planning and testing.
22q11.2 deletion: A small segment on chromosome 22 is missing in one copy. This loss disrupts several nearby genes and drives many features of 22q11.2 deletion syndrome.
TBX1 gene impact: Losing one working copy of a key gene called TBX1 affects heart, palate, and facial development. TBX1 does not explain every feature, but it is a major contributor.
Autosomal dominant: When a parent carries the deletion, each child has a 50% chance of inheriting it. Severity can differ widely, even within the same family.
De novo change: About 85–90% of cases arise for the first time in a child, with parents testing negative. The chance of it happening again in future pregnancies is usually low but not zero.
Parental mosaicism: A parent may carry the deletion in a fraction of their cells, sometimes without clear signs. This can raise recurrence risk for future pregnancies despite a normal blood test.
Repeat-driven breakpoints: The 22q11.2 region contains repeated DNA blocks that make it prone to mis-pairing during egg or sperm formation. This helps explain why the same common deletion size appears in many unrelated families.
Atypical deletions: Some people have smaller or differently placed deletions within 22q11.2. These can cause a similar condition, though the mix and intensity of features may vary.
Variable expressivity: Features range from mild to complex, and cannot be predicted by deletion size alone. Carrying a genetic change doesn’t guarantee the condition will appear. Even within families, needs and outcomes can differ.
Lifestyle risk factors
22q11.2 deletion syndrome is genetic and not caused by lifestyle choices, but daily habits can meaningfully influence symptoms and complications. Understanding how lifestyle affects 22q11.2 deletion syndrome helps families focus on actions that support heart, immune, bone, and mental health. The following elements highlight lifestyle risk factors for 22q11.2 deletion syndrome and how they can shape outcomes across childhood and adulthood.
Inadequate calcium and vitamin D can worsen low calcium levels, raising risk of muscle cramps, tingling, or seizures. Consistent intake and clinician-guided supplementation support bone strength and stabilize calcium after illness or exertion.
Highly processed, low-nutrient diets can aggravate low bone density and raise cardiometabolic strain in those with heart defects or antipsychotic use. Balanced, calorie-appropriate meals help maintain growth, support energy for therapies, and reduce fatty liver or diabetes risks.
Sedentary routines can weaken bones and reduce heart-lung fitness that are important when congenital heart disease or scoliosis are present. Regular, cardiology-approved activity builds stamina, supports mood, and may reduce constipation and sleep problems.
Short or fragmented sleep can intensify attention, learning, and anxiety difficulties common in this condition. A consistent schedule and good sleep hygiene support daytime regulation and may lower behavioral crises.
Risk prevention
22q11.2 deletion syndrome can’t be fully prevented, since the change in DNA happens at or before conception. Prevention focuses on lowering risks from its common features—like infections, heart problems, low calcium, and learning or mental health challenges. Some prevention is universal, others are tailored to people with specific risks. Knowing early symptoms of 22q11.2 deletion syndrome can prompt timely care and reduce complications.
A genetics visit can clarify recurrence risk, offer parental testing, and explain options for a future pregnancy. Choices may include prenatal testing or IVF with embryo testing to lower the chance of passing on the deletion.
During pregnancy, screening and diagnostic tests can check for the deletion and heart differences. Early results help plan delivery at a center ready for newborn heart and breathing support.
Most people with 22q11.2 deletion syndrome benefit from routine vaccines, while live vaccines depend on immune testing. An immunology-guided schedule lowers infection risk and protects close contacts through herd protection.
Good hand hygiene, prompt care for fevers, and timely antibiotics for ear, sinus, or chest infections reduce complications. Extra care during cold and flu season and around sick contacts can help prevent hospital visits.
Transmission
22q11.2 deletion syndrome isn’t contagious—you can’t catch it from someone else. It happens when a small piece of chromosome 22 is missing; in about 9 out of 10 cases the change is new in the child (not inherited). In terms of the genetic transmission of 22q11.2 deletion syndrome, when a parent has the deletion it follows an autosomal dominant pattern, meaning each child has a 1 in 2 (50%) chance of inheriting it. Features can vary widely even within the same family, so a parent may have mild signs while a child’s needs are more complex. If neither parent has the deletion on genetic testing, the chance of it happening again in another pregnancy is low, and a genetics professional can explain options for screening or prenatal testing.
When to test your genes
Consider genetic testing if you or your child has features linked to 22q11.2 deletion syndrome, such as congenital heart differences, palate issues, low calcium, immune problems, or learning/psychiatric concerns. Testing also makes sense for siblings or parents when a family member is diagnosed. Earlier confirmation guides targeted care, surveillance, and family planning.
Diagnosis
Many people first come to evaluation because of a mix of clues—such as a heart difference at birth, feeding troubles from a high-arched or split palate, low calcium, frequent infections, or developmental delays—seen together. For 22q11.2 deletion syndrome, doctors look at these patterns and then confirm the diagnosis with a genetic test on a blood sample. Early and accurate diagnosis can help you plan ahead with confidence. In practice, the genetic diagnosis of 22q11.2 deletion syndrome is most often made with a chromosomal microarray after a careful clinical review.
Doctors review birth history, growth, feeding, speech, and development together with a physical exam. A combination of features can point strongly toward 22q11.2 deletion syndrome.
This is the first-line genetic test to detect the missing piece on chromosome 22. It can find typical and many atypical deletions that older tests might miss.
Fluorescence in situ hybridization (FISH) or MLPA can confirm a known familial deletion or target the common region. These tests may miss smaller or atypical deletions that microarray can detect.
Cell-free DNA screening (NIPT) can flag a possible 22q11.2 deletion during pregnancy. A positive screen is not a diagnosis and should be confirmed with diagnostic testing.
Stages of 22q11.2 deletion syndrome
22q11.2 deletion syndrome does not have defined progression stages. Features vary widely from person to person, can affect several body systems, and often shift with age rather than following a step-by-step decline. Diagnosis is usually confirmed with genetic testing (often a chromosomal microarray), alongside a clinical exam and checks of the heart, immune system, calcium levels, and palate; Different tests may be suggested to help clarify which areas need attention. Doctors then monitor over time based on needs—watching growth and feeding in infancy, speech and learning in childhood, and mental health in adolescence and adulthood—since early symptoms of 22q11.2 deletion syndrome can look different at each stage of life.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with 22q11.2 deletion syndrome, health and day-to-day abilities improve with early diagnosis, coordinated care, and steady follow-up. Heart differences, immune issues, low calcium, feeding or growth concerns, and learning differences often need attention early on. Early care can make a real difference, especially for heart surgery, immune support, speech and feeding therapy, and school planning. Many people ask, “What does this mean for my future?”, and the answer depends on which features are present and how well they’re managed.
Prognosis refers to how a condition tends to change or stabilize over time. Children with 22q11.2 deletion syndrome who receive timely heart repair and good medical support often reach adulthood and can live into middle age and beyond. Development usually continues across childhood and adolescence; some will need educational supports, while others manage with minimal accommodations. Adults may face new or evolving needs, such as anxiety, mood changes, or—less commonly—psychosis; early symptoms of 22q11.2 deletion syndrome–related mental health changes can include social withdrawal, sleep shifts, or a drop in school or work performance. Calcium levels, thyroid function, and bone health deserve periodic checks, since imbalances can cause cramps, fatigue, or fractures if missed.
The outlook is not the same for everyone, but most people with 22q11.2 deletion syndrome do well when heart, immune, and endocrine issues are monitored and treated. Mortality is highest in infancy and early childhood when critical heart defects or severe immune problems are present; with modern care, survival has improved substantially. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Regular follow-up with cardiology, endocrinology, immunology, mental health, and dental care helps reduce complications and supports independence in school, work, and relationships. Talk with your doctor about what your personal outlook might look like.
Long-term effects
People living with 22q11.2 deletion syndrome often see health needs shift from childhood into adulthood, with outlook closely tied to heart health, immune function, and learning and mental health differences. The long-term effects of 22q11.2 deletion syndrome vary widely and can change over time. Many reach adulthood, study or work, and build families, though some medical features may continue or appear later. Overall life expectancy depends on the type and severity of organ differences and the care received early on.
Congenital heart differences may be repaired in childhood, but valve or rhythm issues can persist. Long-term strain on the heart can influence exercise tolerance and lifespan.
Lower T-cell function can mean frequent infections in early life, with some risk of autoimmune conditions later. Susceptibility often improves, but immune differences may persist into adulthood.
Low calcium from parathyroid underactivity can cause tingling, cramps, or seizures. Episodes may recur during illness, stress, or pregnancy, even after years without problems.
Thyroid problems and differences in puberty or growth can occur. Some adults with 22q11.2 deletion syndrome develop low parathyroid function later in life.
How is it to live with 22q11.2 deletion syndrome?
Living with 22q11.2 deletion syndrome often means navigating a mix of medical appointments, learning support, and social or emotional differences that can change with age. Many people do well in school and work with tailored supports, but may need help for speech, learning, heart or immune issues, anxiety, or attention challenges; routines, clear communication, and coordinated care make daily life smoother. Families, caregivers, and friends often play a big role—offering encouragement, helping with logistics, and learning how to spot stress or health changes—while also needing their own support to prevent burnout. With early interventions, community services, and a strengths‑focused plan, many living with 22q11.2 deletion syndrome build meaningful relationships and pursue their goals.
Treatment and drugs
Treatment for 22q11.2 deletion syndrome focuses on the specific needs of each person, since features can affect the heart, immune system, calcium levels, growth, learning, speech, and mental health. Care is usually coordinated by a multidisciplinary team and may include heart surgery if a congenital heart defect is present, calcium and vitamin D to correct low calcium, vaccines and infection-prevention plans for immune problems, speech and feeding therapy, and early developmental and educational supports. Medicines may be used to manage symptoms such as reflux, seizures, attention or mood symptoms, and anxiety; a doctor may adjust your dose to balance benefits and side effects. Beyond medication, other therapies like physical, occupational, and behavioral therapy help with motor skills, daily living, and social communication, while counseling supports emotional health across childhood and adulthood. Regular follow-up is important, as needs can change over time, and genetic counseling can help families understand recurrence risks and plan care.
Non-drug treatment
Living with 22q11.2 deletion syndrome often involves therapies that build communication, learning, and everyday skills at home and school. Recognizing early symptoms of 22q11.2 deletion syndrome can guide timely referrals to supportive services. Non-drug treatments often lay the foundation for progress across childhood and into adulthood. Plans are personalized, and they evolve as needs change.
Team-based services in infancy and preschool focus on speech, movement, feeding, and learning. Starting early can boost developmental progress for children with 22q11.2 deletion syndrome. Services usually happen at home or in community settings.
Therapists work on articulation, expressive language, and understanding language in daily situations. They also help with resonance and nasal speech linked to palate differences in 22q11.2 deletion syndrome. Home practice supports carryover to school and social settings.
Specialists address weak oral muscles, chewing, and swallowing coordination. Strategies can reduce choking risk and make mealtimes less stressful. Care plans adapt as children with 22q11.2 deletion syndrome grow.
Skills like hand strength, handwriting, self-care, and sensory regulation are targeted. Therapists break tasks into manageable steps and build routines for home and school. This can make daily activities feel more achievable.
Your genes may have an impact on how drugs work for you
Medicines for 22q11.2 deletion syndrome can work differently because gene changes affect how the body processes drugs and how sensitive the brain and heart are to them. Pharmacogenetic testing and careful dosing help clinicians choose safer, more effective treatments.
Pharmacological treatments
Medicines for 22q11.2 deletion syndrome are tailored to the specific health issues each person faces, such as low calcium, immune problems, heart concerns, seizures, attention challenges, mood symptoms, or reflux. Early symptoms of 22q11.2 deletion syndrome can include low calcium levels in newborns, which are often treated right away. Not everyone responds to the same medication in the same way. Care is usually stepwise and often combines medicines with nutrition, therapies, and procedures as needed.
Calcium carbonate or citrate can raise low blood calcium. Calcitriol (active vitamin D) helps the body absorb and hold calcium when parathyroid function is low.
Magnesium replacement (oral magnesium oxide or magnesium citrate) can support stable calcium levels. Doctors often check and correct magnesium alongside calcium.
Levothyroxine replaces low thyroid hormone if hypothyroidism develops. Dosing is adjusted slowly based on blood tests and growth or energy changes.
IVIG or SCIG can reduce serious infections when antibody levels or responses are low. Treatment intervals vary, commonly every 3–4 weeks for IVIG or weekly for SCIG.
Genetic influences
In 22q11.2 deletion syndrome, a tiny missing stretch of chromosome 22 removes multiple genes that guide early development, which is why features can involve several body systems. About 9 in 10 cases happen as a new change at conception, while roughly 1 in 10 are inherited from a parent who also has the deletion; in that situation, each child has a 50% chance to inherit it. Doctors call this an autosomal dominant pattern, but the severity varies widely. Even with the same gene change, people can have very different health needs—from mild learning differences to heart or immune problems. Genetic testing that looks for the 22q11.2 deletion can confirm the cause of early symptoms of 22q11.2 deletion syndrome and guide care for the whole family. If neither parent has the deletion on testing, the chance it will happen again in a future pregnancy is low; a genetic counselor can review your family history and discuss options.
Is 22q11.2 deletion syndrome genetic?
Genetics are central in 22q11.2 deletion syndrome: the condition results from a small missing segment on chromosome 22. Most cases occur as new (de novo) changes; some are inherited in an autosomal dominant pattern. Genetic testing confirms the deletion and guides family counseling.
Pharmacogenetics—how genetics influence drug effects
For people with 22q11.2 deletion syndrome, genetics can shape how certain medicines work, what dose feels comfortable, and which side effects are more likely. The deletion often removes one copy of a gene called COMT, which helps clear dopamine and related brain chemicals; with only one working copy, some may be more sensitive to stimulants or antipsychotics and benefit from slower, smaller dose changes. The specific version of COMT on the remaining copy (often discussed as Val or Met) can tilt its activity up or down, which may influence side effects such as restlessness, anxiety, or movement symptoms. Separate from the deletion itself, common drug‑metabolism genes like CYP2D6 and CYP2C19 can affect response to medicines frequently used in 22q11.2 deletion syndrome, including some antidepressants, antipsychotics, and pain medicines.
Genetic testing can sometimes identify how your body handles these drugs, so pharmacogenetic testing in 22q11.2 deletion syndrome may help guide safer starting doses and closer monitoring where needed. Doctors also fold in individual factors—heart rhythm risks, calcium levels, seizure history, and other health conditions—to choose and adjust medicines over time. Age, other prescriptions, and overall health still play a big role, so plans are personalized and revisited as needs change.
Interactions with other conditions
Day to day, infections, feeding issues, or anxiety can feel bigger hurdles when you’re also managing heart or palate differences related to 22q11.2 deletion syndrome. Doctors call it a “comorbidity” when two conditions occur together. Because immune function can be reduced, colds, ear infections, and pneumonia may happen more often or last longer, and autoimmune problems like thyroid disease or low platelets can develop and complicate care around heart surgery or dental work. Palate differences and reflux can interact with asthma or recurrent sinus infections, making breathing, sleep, and growth harder than expected. Early symptoms of 22q11.2 deletion syndrome can overlap with autism, ADHD, or learning differences, and these neurodevelopmental conditions may intensify sleep problems or anxiety, which in turn can affect school, work, and social life. Some medicines used for attention, mood, or psychosis need careful selection if there’s a history of heart rhythm issues, seizures, or kidney differences, so coordinated care helps balance benefits and risks across conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who were small for their age, had frequent infections, and later struggled with learning or speech, even if the exact cause wasn’t known. Families and communities once noticed patterns—an uncle with a cleft palate, a cousin with heart surgery in infancy—without realizing these features could be linked. Doctors wrote case notes about newborns with complex heart defects and low calcium, or teens with nasal-sounding speech and anxiety, but these were viewed as separate problems.
From early theories to modern research, the story of 22q11.2 deletion syndrome moved from scattered clues to a single explanation. In the mid-20th century, certain clusters of features—heart differences, immune problems, and a distinct facial appearance—were described under names like DiGeorge or velocardiofacial syndromes. Initially understood only through symptoms, later work showed these patterns often overlapped, hinting at a shared cause. As genetic tools improved in the late 1980s and early 1990s, researchers found that a small missing piece on chromosome 22 (at region q11.2) could explain many of these cases. This discovery connected what had seemed like different conditions into one spectrum.
Once considered rare, now recognized as more common than many realized, 22q11.2 deletion syndrome is diagnosed in about 1 in 3,000 to 1 in 6,000 births. The shift came with wider use of chromosomal tests—first fluorescent in situ hybridization (FISH), and later microarray and targeted assays—which made the deletion easier to detect. With better tools, clinicians began to identify not only babies with severe heart defects, but also children and adults with milder features who had gone undiagnosed for years.
Over time, descriptions became more complete. Early reports focused on newborn crises—low calcium, infections, urgent heart surgery. Later studies followed children into school and adulthood, documenting speech differences, learning and attention challenges, mood and anxiety conditions, and, for some, psychosis in late adolescence or adulthood. This broader view helped families and clinicians plan long-term care and recognize that 22q11.2 deletion syndrome can vary widely, even within the same family.
In recent decades, awareness has grown as parent groups, clinicians, and researchers worked together, improving early testing and coordinated care. Historical differences highlight why some people only receive a diagnosis in adulthood, often after a child is tested. Knowing the condition’s history helps explain today’s approach: connect the dots early, offer genetic counseling, and tailor support across the lifespan so people living with 22q11.2 deletion syndrome can reach their potential.